Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.2% | −8.2% | −9.3% | −8.5% | — | — | — | — | — | +4.9% |
| Peer average | −5.1% | −10.2% | −12.8% | −14.4% | −7.3% | −3.6% | +48.7% | +30.6% | +308.6% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$91 of every $1,000 in RKSG is Apple
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | AAPLApple | Technology | 9.13% | $912.51 | 710 | $248K |
| 2 | NVDANvidia | Technology | 7.31% | $730.68 | 1,360 | $199K |
| 3 | MSFTMicrosoft | Technology | 5.23% | $522.67 | 285 | $142K |
| 4 | GOOGLAlphabet | Communication Services | 4.87% | $486.69 | 485 | $132K |
| 5 | LLYEli Lilly | Healthcare | 4.23% | $422.67 | 85 | $115K |
| 6 | AMZNAmazon | Consumer Cyclical | 3.32% | $331.53 | 350 | $90K |
| 7 | AVGOBroadcom | Technology | 2.23% | $223.27 | 175 | $61K |
| 8 | METAMETA Platforms | Communication Services | 2.19% | $219.43 | 100 | $60K |
| 9 | JNJJohnson & Johnson | Healthcare | 2.02% | $201.55 | 205 | $55K |
| 10 | ABBVAbbVie | Healthcare | 1.88% | $187.84 | 180 | $51K |
| 11 | MRKMerck | Healthcare | 1.83% | $183.30 | 375 | $50K |
| 12 | KOCoca-Cola /The | Consumer Defensive | 1.64% | $164.45 | 465 | $45K |
| 13 | LMTLockheed Martin | Industrials | 1.58% | $157.85 | 75 | $43K |
| 14 | REGNRegeneron Pharmaceuticals | Healthcare | 1.53% | $152.77 | 45 | $42K |
| 15 | ALLAllstate /The | Financial Services | 1.52% | $152.18 | 155 | $41K |
Not enough history yet: RKSG needs a year of prices.
RKSG does not pay a distribution.
of the $525B in 113 Growth ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | AAPL | Apple | 9.13% |
| 2 | NVDA | Nvidia | 7.31% |
| 3 | MSFT | Microsoft | 5.23% |
| 4 | GOOGL | Alphabet | 4.87% |
| 5 | LLY | Eli Lilly & | 4.23% |
| 6 | AMZN | Amazon | 3.32% |
| 7 | AVGO | Broadcom | 2.23% |
| 8 | META | META Platforms | 2.19% |
| 9 | JNJ | Johnson & Johnson | 2.02% |
| 10 | ABBV | AbbVie | 1.88% |
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]